FGFR3 mutations in benign skin tumors

Area of Science:

• Dermatology and Molecular Biology
• Oncology
• Genetics

Background:

• Activating mutations in the Fibroblast Growth Factor Receptor 3 (FGFR3) gene are known causes of skeletal dysplasias and craniosynostosis syndromes.
• Somatic FGFR3 mutations have also been implicated in various cancers, including urothelial carcinoma and multiple myeloma.
• Recently, these specific FGFR3 mutations have been identified in benign human skin tumors, such as seborrheic keratoses and epidermal nevi.

Purpose of the Study:

• To discuss the potential mechanisms and functional consequences of activating FGFR3 mutations in human skin.
• To explore the signaling pathways involved in mutant keratinocytes leading to acanthotic skin tumor formation.
• To highlight the need for further research into the pathogenesis of benign skin tumors caused by FGFR3 mutations.

Main Methods:

• Review and discussion of existing literature on FGFR3 mutations in skeletal disorders, cancers, and skin tumors.
• Exploration of potential molecular mechanisms and signaling pathways in keratinocytes.
• Identification of knowledge gaps requiring further experimental investigation.

Main Results:

• FGFR3 mutations, common in skeletal conditions and cancers, are now recognized as a cause of benign skin tumors.
• The specific mechanisms and signaling pathways driving these skin tumors in mutant keratinocytes remain largely unknown.
• The study posits that understanding these mechanisms is crucial for future therapeutic strategies.

Conclusions:

• Activating FGFR3 mutations play a role in the pathogenesis of benign acanthotic skin tumors.
• Further research is essential to elucidate the underlying molecular mechanisms and signaling pathways.
• Insights gained could lead to novel, non-invasive therapeutic approaches in dermatology for these skin conditions.